Myomo (STU:0M61) Change In Payables And Accrued Expense : €5.81 Mil (TTM As of Mar. 2025)

View and export this data going back to 2017. Start your Free Trial

What is Myomo Change In Payables And Accrued Expense?

Myomo's Change In Payables And Accrued Expense for the quarter that ended in Mar. 2025 was €1.33 Mil. It means Myomo's Accounts Payable & Accrued Expense increased by €1.33 Mil from Dec. 2024 to Mar. 2025 .

Myomo's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2024 was €4.71 Mil. It means Myomo's Accounts Payable & Accrued Expense increased by €4.71 Mil from Dec. 2023 to Dec. 2024 .

Myomo Change In Payables And Accrued Expense Historical Data

The historical data trend for Myomo's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Myomo Change In Payables And Accrued Expense Chart

Myomo Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

1.00

0.99

-0.67

1.60

4.71

Myomo Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															0.15	0.93	0.84	2.71	1.33

Myomo Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €5.81 Mil.

Myomo Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Myomo's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Myomo Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Myomo Inc (STU:0M61) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

MYO:USA 0M61:Germany

Address

45 Blue Sky Drive, Suite 101, Burlington, MA, USA, 01803

Website

https://www.myomo.com

Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).

Myomo Headlines

No Headlines